Hartmut Döhner

56PUBLICATIONS
406CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Nov 01, 2026
Prognostic Impact of FLT3-ITD Microclones in AML: An EHA AML-Specialized Working Group Study.

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Jun 25, 2026
Rapid and reproducible karyotyping with long-read sequencing in patients with AML.

|Feb 09, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng

|Jan 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study.

Alberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng

|Jan 06, 2026
A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Hartmut Döhner, Daniela Späth, Maral Saadati

Pageof 10

Frequent Collaborators

14 joint publications

Konstanze Döhner

12 joint publications

Michael Heuser

10 joint publications

Courtney D DiNardo

7 joint publications

Pau Montesinos